Results 151 to 160 of about 385,065 (234)

Abatacept in B7-1-positive proteinuric kidney disease.

open access: yesNew England Journal of Medicine, 2014
A. Greka, Astrid Weins, P. Mundel
semanticscholar   +1 more source

B7-H3 and GD2 overexpression as immunotherapeutic targets in retinoblastoma. [PDF]

open access: yesSci Rep
Sujjitjoon J   +10 more
europepmc   +1 more source

c-JUN enhances CRISPR knockin anti-B7-H3 CAR T cell function in small cell lung cancer and thoracic SMARCA4-deficient undifferentiated tumors. [PDF]

open access: yesCell Rep Med
Balke-Want H   +25 more
europepmc   +1 more source

B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escape. [PDF]

open access: yesJ Hematol Oncol
Van der Vreken A   +21 more
europepmc   +1 more source

Natural Killer Cells in Cancer Immunotherapy [PDF]

open access: yes, 2019
Arndt MA   +15 more
core   +1 more source

Exploiting B7-H3: Molecular Insights and Immunotherapeutic Strategies for Osteosarcoma. [PDF]

open access: yesBioengineering (Basel)
Xie Y   +6 more
europepmc   +1 more source

Multifunctional HBc Virus-Like Particles Reprogram Immunosuppressive Macrophages and Potentiate CD8+ T Cell Responses for Enhanced Cancer Immunotherapy

open access: yesInternational Journal of Nanomedicine
Shuntao Liang,1,* Xiaoxuan Yin,1,* Yongjie Chi,2,3,* Keyue Wang,1,* Li Ma,4 Zhu Yang,2,3 Xin Xue,5 Shoucheng Wang,2,6 Kai Zhao,6 Lianyan Wang,2,3 Juan Ma1 1Biomedical Innovation Center, Beijing Shijitan Hospital, Capital ...
Liang S   +10 more
doaj  

Home - About - Disclaimer - Privacy